PERSONAL GENOME DIAGNOSTICS INC.

Profile

Company Names

PERSONAL GENOME DIAGNOSTICS INC.

Addresses

2809 BOSTON STREET, SUITE 503, BALTIMORE, MD 21224

855 N. WOLFE STREET, SUITE 629, BALTIMORE, MD 21205

Phone Numbers

(443) 602-8833
410-558-1201

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

MARYLAND

Total Amount Raised:

$198,120,828.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2021-02-05 
$97,729,418.00 
$98,295,724.00 
$566,306.00 
Equity 
7
2020-05-09 
$2,750,000.00 
$3,550,000.00 
$800,000.00 
Debt 
6
2019-06-07 
$5,000,000.00 
$20,000,000.00 
$15,000,000.00 
Debt 
5
2017-10-13 
$65,367,412.00 
$111,517,424.00 
$46,150,012.00 
Equity 
4
2015-10-23 
$20,451,998.00 
$21,445,808.00 
$993,810.00 
Equity 
3
2015-05-20 
$4,322,000.00 
INDEFINITE 
INDEFINITE 
Debt 
2
2014-03-07 
$2,000,000.00 
$3,500,000.00 
$1,500,000.00 
Equity 
1
2011-08-31 
$500,000.00 
$500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAM 
 
ANGIUOLI 
EXECUTIVE OFFICER
SAM 
 
ANGUIOLI 
EXECUTIVE OFFICER
SAMUEL 
 
ANGUIOLI 
EXECUTIVE OFFICER
MEGAN 
 
BAILEY 
EXECUTIVE OFFICER, DIRECTOR
JEFF 
 
BOSCHWITZ 
EXECUTIVE OFFICER
CINDY 
 
CACCURO 
EXECUTIVE OFFICER
JACK 
 
CROWLEY 
DIRECTOR, EXECUTIVE OFFICER
FELIX 
 
DAWSON 
DIRECTOR
LUIS 
 
DIAZ 
EXECUTIVE OFFICER
LUIS 
A. 
DIAZ, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
SCOTT 
 
GOTSHALL 
EXECUTIVE OFFICER
SIAN 
 
JONES 
EXECUTIVE OFFICER
LISA 
 
KANN 
EXECUTIVE OFFICER
KENNETH 
W. 
KINZLER 
PROMOTER
JAMES 
 
LAFRANCE 
DIRECTOR
ANTHONY 
 
NEWTON 
EXECUTIVE OFFICER
KEVIN 
 
REIDY 
DIRECTOR
MARK 
 
SAUSEN 
EXECUTIVE OFFICER
WILLIAM 
 
STEVENS 
EXECUTIVE OFFICER
WILLIAM 
STEVENS 
EXECUTIVE OFFICER
WILLIAM 
J. 
STEVENS 
EXECUTIVE OFFICER
VICTOR 
 
VELCULESCU 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BERT 
 
VOGELSTEIN 
PROMOTER
DOUGLAS 
 
WARD 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-05-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
PICKWICK CAPITAL PARTNERS, LLC
JOHN K. DIERKES